idsMED Healthcare Go Global Summit – “ASEAN Bound: Strategic Insights for Chinese MedTech Expansion”

On the afternoon of 7 November 2025, from 14:00 to 17:00, idsMED—part of the Fung Group of Companies—successfully held the idsMED Healthcare Go Global Summit 2025 at LiFung Plaza, 2000 Yishan Road, Shanghai, China. The event, themed “ASEAN Bound: Strategic Insights for Chinese Medical Equipment Manufacturers’ Overseas Expansion,” gathered more than 109 participants, including healthcare manufacturers, distributors, policymakers, and investors, to explore overseas expansion opportunities through collaboration with idsMED Group.

China’s medical equipment and consumables manufacturers are at a pivotal inflexion point in their global development. With rising healthcare demand, favourable industrial policies, and increasingly harmonised regulatory frameworks, ASEAN has become one of the most strategic regions for international growth. Beyond being a fast-expanding market of nearly 700 million people, ASEAN also offers compelling advantages as a regional manufacturing base, strengthening supply-chain resilience, reducing costs, and accelerating market access.

This summit was created precisely to meet these needs. It provides Chinese medical equipment and consumables manufacturers with government-level perspectives, healthcare policy priorities, regulatory frameworks, investment incentives, and real-world case studies to help them build successful and sustainable ASEAN expansion strategies. The forum is aimed at Chinese MedTech companies that wish to:

• Expand into ASEAN healthcare markets
• Establish or diversify manufacturing in ASEAN
• Strengthen supply chains and reduce dependency risk

Backed by idsMED’s extensive regional experience, the summit offered clarity, direction, and actionable insights to help participants seize emerging opportunities.

Hosted by idsMED Group, a leading Southeast Asian medical supply chain enterprise under the Fung Group, the summit received strong support from the Group. Headquartered in Hong Kong, the Fung Group is a privately owned multinational organisation with a heritage dating back to 1906. Originally founded as an export trading business, it has evolved into a global supply chain management group spanning trading, logistics, distribution, and retail. Fung Holdings remains the major shareholder of the Group.

As one of Asia’s largest integrated solution providers for medical equipment, consumables, and related services, idsMED Group operates an extensive distribution network serving medical institutions across six major ASEAN countries. Its comprehensive solutions and deep local expertise provide global partners—including Chinese manufacturers—with strategic guidance for sustainable market entry.

Key Takeaways from the Forum

The summit brought together distinguished speakers and industry leaders whose insights shaped the day’s discussions. In the opening keynote, Dr. Victor Fung, Chairman of Fung Investments, underscored the importance of regional integration and long-term partnerships in driving healthcare expansion. He highlighted how supply chain resilience and localised collaboration will increasingly define post-pandemic success for the medical trade and innovation.

The first thematic session provided a comprehensive overview of opportunities in key ASEAN markets:

• Malaysia
  Mr. Abu Bakar Yusof, Deputy CEO of MATRADE, outlined Malaysia’s growing medical device sector and internationally aligned regulatory system. He encouraged Chinese companies to explore joint ventures and technology transfer opportunities through Malaysia’s thriving MedTech hubs.

• Thailand
  Dr. Sittiluck Wongwantanee, M.D., Deputy Director of the Health Administration Division at Thailand’s Ministry of Public Health, outlined the country’s key policies and priorities in digital health, medical tourism, and the sustainability of universal healthcare. He also clarified the regulatory approval processes of the Thai FDA, the classification of medical device risk categories, and emerging opportunities in hospital modernisation.

• Indonesia
  Mr. Aristo Setiawidjaja, Special Advisor to the Minister of Health, introduced Indonesia’s Health Transformation Agenda 2025, emphasising local manufacturing, primary care reform, and large-scale infrastructure development. He welcomed Chinese firms to participate in technology localisation and capacity-building initiatives.

The second session focused on practical pathways and case studies for entering ASEAN markets:

• idsMED Group Perspective
  Mr. Rufi Susanto, Group President of idsMED, shared the organisation’s extensive experience in bridging China and ASEAN through cross-border distribution and partnership networks. He highlighted manufacturers that achieved rapid regional growth by leveraging idsMED’s platforms, reinforcing that selecting the right local partner is often the decisive factor for long-term success.
• Industry Case Studies

• Mr. Pavel Lu of Shenzhen Edge Medical and Mr. Zhang Jindi, Founder & CEO of Surgnova Healthcare Technologies, presented expansion journeys in Malaysia, Indonesia, and Vietnam.
  Their insights emphasised:
  • adapting to local regulatory standards
  • establishing robust after-sales service systems
  • investing in cultural alignment to build trust
  • developing long-term local partnerships

Across all sessions, the summit reinforced several overarching insights. ASEAN’s fast-growing healthcare demand and rapid digital transformation present substantial opportunities for Chinese medical device companies. However, sustainable market entry requires a deep understanding of regulatory environments and meaningful partnerships with local stakeholders. idsMED’s established regional network and expertise continue to play a pivotal role in bridging business ecosystems between China and ASEAN, enabling collaborative and long-term expansion strategies that outperform transactional approaches.

Participants expressed strong appreciation for the strategic clarity, actionable insights, and networking opportunities offered throughout the event. The success of the summit was made possible through the leadership of Mr. Rufi Susanto and the dedicated efforts of Mr. Bohu (Director, Agency and Product Development), Ms. WernMey Tan (Product and Clinical Support Manager), and the entire idsMED China team.